KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories

Roberto Serna-Blasco1, Karla Medina2, María Ángeles Sala3

  • 1Department of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain; Liquid Biopsy Laboratory, Department of Medical Oncology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.

Chest
|July 17, 2025
PubMed
Abstract

Insights

Occupational exposures are linked to specific KRAS mutations in non-small cell lung cancer (NSCLC). Different jobs show varied KRAS mutation patterns, impacting lung cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Occupational Health

Background:

  • Lung cancer is a leading cause of cancer mortality globally.
  • Occupational carcinogen exposure is a significant, yet understudied, factor in lung cancer etiology.
  • Understanding the molecular impact of occupational exposures is crucial for targeted prevention and treatment.

Purpose of the Study:

  • To investigate the association between occupational carcinogen exposure and the molecular profile of metastatic non-small cell lung cancer (NSCLC).
  • To identify specific occupations linked to distinct KRAS mutation prevalence and subtypes in NSCLC patients.

Main Methods:

  • Analysis of 302 metastatic NSCLC patients without EGFR/ALK mutations.
  • Detailed occupational histories classified using ISCO, Adapted Classification (AC), and IARCC.
  • Next-generation sequencing of tumor biopsy specimens to identify KRAS mutations.
  • Statistical comparisons between occupational groups and the overall cohort.

Main Results:

  • Higher KRAS mutation prevalence observed in cooks, painters, Personal Service Workers, and Building and Related Trades Workers.
  • Lower KRAS mutation frequencies noted in office workers and those with low/no exposure.
  • Distinct KRAS mutation subtypes identified across occupations, including G12C in Personal Service Workers, G12A in painters, and G12D in chemically exposed workers.

Conclusions:

  • Occupational exposures are significantly associated with specific KRAS mutation prevalence in NSCLC.
  • Different job categories exhibit unique KRAS mutation patterns, highlighting the role of occupation in lung cancer molecular pathogenesis.
  • Findings underscore the importance of considering occupational history in NSCLC research and clinical practice.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
540
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K